Solanezumab funciona bloqueando la proteína beta amiloide que forma depósitos de placas en el cerebro. Más
Un fármaco en desarrollo podría reducir en un 30% la pérdida de memoria en pacientes de Alzheimer.
. En: Actualidad 
- Experiences of patients living with HIV and AIDS on antiretroviral therapy in Accra, Ghana 06/05/2024
- Determinants of antiretroviral therapy adherence among transgender women in South Africa 06/05/2024
- Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis 06/05/2024
- Nature and evolution of the cellular HIV-1 reservoir in children and adolescents 06/05/2024
- Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals 06/05/2024
 |
 |
 |
 |
- DDT pollutants found in deep sea fish off Los Angeles coast 06/05/2024
- Past and guides future efforts to reduce cancer disparities 06/05/2024
- Simulated chemistry: New AI platform designs tomorrow's cancer drugs 06/05/2024
- Expanding a lymph node, boosting a vaccine 06/05/2024
- Self-critical perfectionism gnaws on students' well-being already in lower secondary school 06/05/2024
 |
1 de mayo de 2024
| Sitio presentado el 18 de mayo de 2010 |  |
DE NUESTROS LECTORES